{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:35:47Z","timestamp":1771065347173,"version":"3.50.1"},"reference-count":32,"publisher":"SLACK, Inc.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Refract Surg"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the safety and effectiveness of a new aspheric ablation profile for correcting myopia and myopic astigmatism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This prospective, multicenter study included patients who underwent laser in situ keratomileusis (LASIK) using a new aspheric ablation profile of the Technolas Teneo 317 (Model 2) excimer laser (version 1.28 US SW) by Technolas Perfect Vision, Bausch+Lomb, Inc. No nomogram adjustments were made, and the patient's manifest refraction was entered into the laser (for treatment). Postoperative assessments included visual and refractive outcomes. Patients were asked to complete the Patient-Reported Outcomes With LASIK (PROWL) questionnaire preoperatively and postoperatively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 333 eyes from 168 patients with a mean age of 33 \u00b1 7 years were included. At postoperative 9 months, uncorrected and corrected distance visual acuities of 20\/25 or better were seen in 97.8% and 100% of eyes, respectively. None of the eyes lost two or more lines of corrected distance visual acuity. The mean manifest spherical refraction improved from \u22125.67 \u00b1 2.52 diopters (D) preoperatively to \u22120.04 \u00b1 0.32 D postoperatively, with 92.7% of eyes achieving residual refractive error within \u00b10.50 D. Residual refractive cylinder within \u00b10.50 and \u00b11.00 D was seen in 93% and 99.4% eyes, respectively. The refractive outcomes were stable throughout the follow-up of 9 months. The proportion of patients satisfied with their vision rose from 27.7% preoperatively to 98.1% postoperatively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>LASIK performed using a new aspheric ablation profile of the Technolas Teneo 317 (Model 2) excimer laser is safe and effective for correcting myopia and myopic astigmatism, yielding excellent visual and refractive outcomes that were stable over 9 months.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                [\n                <jats:italic>J Refract Surg<\/jats:italic>\n                . 2024;40(8):e544\u2013e553.]\n              <\/jats:bold>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/1081597x-20240611-03","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T11:43:40Z","timestamp":1723203820000},"source":"Crossref","is-referenced-by-count":4,"title":["Safety and Effectiveness of Laser in Situ Keratomileusis Using the Teneo 317 Model 2 for Correcting Myopia and Myopic Astigmatism: Results of the U.S. FDA Clinical Trial"],"prefix":"10.3928","volume":"40","author":[{"suffix":"IV","given":"George O.","family":"Waring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Stonecipher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lobanoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Ralph","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Endl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg","family":"Feinerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lester O.","family":"Hosten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20100921-01"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.5455\/aim.2019.27.278-283"},{"issue":"2","key":"e_1_3_3_4_2","first-page":"S277","article-title":"Abstracts-LASIK in 3946 eyes with the Nidek EC-5000 excimer Laser","volume":"17","author":"Waring GO","year":"2001","unstructured":"Waring GO III, Stulting RD, Wiley WM, Garr JD, Thompson KP. Abstracts-LASIK in 3946 eyes with the Nidek EC-5000 excimer Laser. J Refract Surg. 2001;17(2):S277.","journal-title":"J Refract Surg"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(13)80648-7"},{"key":"e_1_3_3_6_2","first-page":"293","volume-title":"The Art of LASIK","author":"Kezirian G","year":"1999","unstructured":"Kezirian G, Casebeer JC. The CRS LASIK study. In: Machat JJ, Slade SG, Probst LE, eds. The Art of LASIK.SLACK Incorporated; 1999:293\u2013302."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.23.2.020901"},{"issue":"4","key":"e_1_3_3_8_2","first-page":"S424","article-title":"Wavefront-optimized versus wavefront-guided LASIK for myopic astigmatism with the ALLEGRETTO WAVE: three-month results of a prospective FDA trial","volume":"24","author":"Stonecipher KG","year":"2008","unstructured":"Stonecipher KG, Kezirian GM. Wavefront-optimized versus wavefront-guided LASIK for myopic astigmatism with the ALLEGRETTO WAVE: three-month results of a prospective FDA trial. J Refract Surg. 2008;24(4):S424\u2013S430. PMID:18500097","journal-title":"J Refract Surg"},{"issue":"4","key":"e_1_3_3_9_2","first-page":"S431","article-title":"Four-year postoperative results of the US ALLEGRETTO WAVE clinical trial for the treatment of hyperopia","volume":"24","author":"Kezirian GM","year":"2008","unstructured":"Kezirian GM, Moore CR, Stonecipher KG; SurgiVision Consultants Inc WaveLight Investigator Group. Four-year postoperative results of the US ALLEGRETTO WAVE clinical trial for the treatment of hyperopia. J Refract Surg. 2008;24(4):S431\u2013S438. PMID:18500098","journal-title":"J Refract Surg"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20100921-08"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20100921-09"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.04.010"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.17925\/USOR.2012.05.01.14"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-813270"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2015.08.016"},{"key":"e_1_3_3_16_2","volume-title":"Advanced CustomVue Myopia Treatment Professional Use Manual","author":"Abbott Medical Optics Inc","year":"2015","unstructured":"Abbott Medical Optics Inc. Advanced CustomVue Myopia Treatment Professional Use Manual. Abbott Medical Optics Inc, 2015. Accessed June 15, 2023. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/P930016S044c.pdf"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0629"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(99)00011-5"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030399"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2016.06.035"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20141021-10"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.4103\/JCRS.JCRS_16_17"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1916_19"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(01)00254-5"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001617"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/1120672119865688"},{"issue":"4","key":"e_1_3_3_27_2","first-page":"265","article-title":"Complications of laser-in-situ-keratomileusis","volume":"50","author":"Sridhar MS","year":"2002","unstructured":"Sridhar MS, Rao SK, Vajpayee RB, Aasuri MK, Hannush S, Sinha R. Complications of laser-in-situ-keratomileusis. Indian J Ophthalmol. 2002;50(4):265\u2013282. PMID:12532491","journal-title":"Indian J Ophthalmol"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2017.09.023"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3765046"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-014-9919-7"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2017.09.002"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2012.03.018"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-2"}],"container-title":["Journal of Refractive Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T11:44:14Z","timestamp":1723203854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/1081597X-20240611-03"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.3928\/1081597X-20240611-03"],"URL":"https:\/\/doi.org\/10.3928\/1081597x-20240611-03","relation":{},"ISSN":["1081-597X"],"issn-type":[{"value":"1081-597X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}